切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (03) : 361 -363. doi: 10.3877/cma.j.issn.1673-5250.2013.03.018

所属专题: 文献

短篇论著

血管瘤-血小板减少综合征的临床分析
牛利美1, 石晶1,*(), 熊英1   
  1. 1. 610041 成都,四川大学华西第二医院新生儿科
  • 收稿日期:2012-11-25 修回日期:2013-04-15 出版日期:2013-06-01
  • 通信作者: 石晶
  • 基金资助:
    资金资助项目:卫生部国家临床重点专科建设项目(2011873)
  • Received:2012-11-25 Revised:2013-04-15 Published:2013-06-01
引用本文:

牛利美, 石晶, 熊英. 血管瘤-血小板减少综合征的临床分析[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(03): 361-363.

图1 治疗前患儿临床体征
Figure 1 Physical signs of KMS patient before treatment
图2 治疗后患儿体征明显好转
Figure 2 Significant improvement of physical signs in KMS patient after treatment
[1]
Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura[J].Am J Dis Child, 1940, 59:1063-1079.
[2]
Cheerva AC, Bartolone S, Raj AB.Pediatric Kasabach-Merritt syndrome[N/OL]. Medscape reference, 2010-02-23.
[3]
Chen H.Atlas of genetic diagnosis and counseling[M].New York:Springer, 2012:1211-1214.
[4]
Ryan C, Price V, John P, et al.Kasabach-Merritt phenomenon: A single centre experience[J]. Eur J Haematol, 2010, 84(2):97-104.
[5]
Lei HZ, Sun B, Liu DK, et al. Combined and sequential therapy for Kasabach-Merritt syndrome[J].Natl Med J China, 2011, 91(36):2538-2541.
[6]
Peker E, Kirimi E, Tuncer O, et al.Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach-Merritt syndrome: Successful management with interferon alpha[J].Platelets, 2009, 20(8):603-605.
[7]
Kim T, Roh MR, Cho S, et al. Kasabach-merritt syndrome arising from tufted angioma successfully treated with systemic corticosteroid[J]. Ann Dermatol, 2010, 22(4):426-430.
[8]
Rodriguez V, Lee A, Witman PM, et al. Kasabach-Merritt phenomenon case series and retrospective review of the mayo clinic experience[J]. J Pediatr Hematol Oncol, 2009, 31:522-526.
[9]
Koerper MA, Addiego JE Jr, de Lorimier AA, et al.Use of aspirin and dipyridamole in children with platelet trapping syndromes[J]. J Pediatr, 1983, 102(2):311-314.
[10]
Tang JY, Chen J, Pan C, et al. Diffuse hemangioma of the spleen with Kasabach-Merritt syndrome misdiagnosed as idiopathic thrombocytopenia in a child[J].World J Pediatr, 2008, 4(3):227-230
[11]
Krafchik BR, Hendricks LK, Faquet GB. Kasabach-Merritt syndrome[N/OL]. Medscape reference, 2010-2-22.
[12]
Georgina W.Hall Kasabach-Merritt syndrome:Pathogenesis and management[J]. Br J Haematol, 2001, 112(4):851-862.
[13]
Frevel T, Rabe H, Uckert F, et al.Giant cavernous haemangioma with Kasabach-Merritt syndrome: A case report and review[J]. Eur J Pediatr, 2002, 161:243-246.
[14]
Jiang RS, Hu R. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery[J].Int J Clin Oncol, 2012, 17(5):512-516.
[15]
Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, et al.Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: Successful treatment with vincristine and ticlopidine[J]. Indian J Pediatr, 2012, 79(10):1386-1387.
[16]
Yoon HS, Lee JH, Moon HN, et al. Successful treatment of retroperitoneal infantile hemangioendothelioma with Kasabach-Merritt syndrome using steroid, a-interferon, and vincristine[J]. J Pediatr Hematol Oncol, 2009, 31:952-954.
[17]
Shen W, Cui J, Chen J, et al. Kasabach-Merritt with partial resection of tumor, reduction of tumor blood, and vincristine chemotherapy[J]. J Craniofac Surg, 2010, 21(1):215-216.
[18]
Folkman J, Browder T, Palmblad J, et al. Angiogenesis research: guidelines for translation to clinical application[J]. Thromb Haemost, 2001, 86(1):23-33.
[19]
Hermans DJ, van Beynum IM, van der Vijver RJ, et al.Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: A new indication for propranolol treatment[J]. J Pediatr Hematol Oncol, 2011, 33(4):171-173.
[20]
Guldbakke KK, Rordam OM, Huldt-Nystrom T, et al. Propanolol used in treatment of infantile hemangioma[J]. Tidsskr Nor Laegeforen, 2010, 130:1822-1824.
No related articles found!
阅读次数
全文


摘要